Amide-based inhibitors of p38α MAP kinase. Part 2: Design, synthesis and SAR of potent N-pyrimidyl amides

Optimization of a tri-substituted N-pyridyl amide led to the discovery of a new class of potent N-pyrimidyl amide based p38α MAP kinase inhibitors. Initial SAR studies led to the identification of 5-dihydrofuran as an optimal hydrophobic group. Additional side chain modifications resulted in the introduction of hydrogen bond interactions. Through extensive SAR studies, analogs bearing free amino groups and alternatives to the parent (S)-α-methyl benzyl moiety were identified. These compounds exhibited improved cellular activities and maintained balance between p38α and CYP3A4 inhibition.

Identification and optimization of a new class of N-pyrimidyl amide based p38α MAP kinase inhibitors is described. The lead structure was derived from a previously reported class of pyridine-based amides. p38α activity (enzymatic/cellular) and CYP3A4 data for the new series are presented.Figure optionsDownload as PowerPoint slide